Cancer testis antigens in newly diagnosed and relapse multiple myeloma: prognostic markers and potential targets for immunotherapy.
van Duin, Mark, Broyl, Annemiek, de Knegt, Yvonne, Goldschmidt, Hartmut, Richardson, Paul G, Hop, Wim C J, van der Holt, Bronno, Joseph-Pietras, Debora, Mulligan, George, Neuwirth, Rachel, Sahota, Surinder S. and Sonneveld, Pieter (2011) Cancer testis antigens in newly diagnosed and relapse multiple myeloma: prognostic markers and potential targets for immunotherapy. Haematologica, 96, (11), 1662-1669. (doi:10.3324/haematol.2010.037978). (PMID:21791470).
Download
Full text not available from this repository.
Description/Abstract
Relapsed multiple myeloma reveals extensive cancer testis antigen expression. Cancer testis antigens are confirmed as useful prognostic markers in newly diagnosed multiple myeloma patients and in relapsed multiple myeloma patients. The HOVON-65/GMMG-HD4 trial is registered under Dutch trial register n. NTR-213. CREST, SUMMIT and APEX trials were registered under ns. M34100-024, M34100-025 and NCT00049478/NCT00048230, respectively.
| Item Type: | Article |
|---|---|
| ISSNs: | 0390-6078 (print) 1592-8721 (electronic) |
| Related URLs: | |
| Subjects: | R Medicine > RC Internal medicine > RC0254 Neoplasms. Tumors. Oncology (including Cancer) |
| Divisions: | Faculty of Medicine > Cancer Sciences |
| Item ID: | 339787 |
| Date Deposited: | 30 May 2012 13:16 |
| Last Modified: | 26 Apr 2013 06:05 |
| Contributors: | van Duin, Mark (Author) Broyl, Annemiek (Author) de Knegt, Yvonne (Author) Goldschmidt, Hartmut (Author) Richardson, Paul G (Author) Hop, Wim C J (Author) van der Holt, Bronno (Author) Joseph-Pietras, Debora (Author) Mulligan, George (Author) Neuwirth, Rachel (Author) Sahota, Surinder S. (Author) Sonneveld, Pieter (Author) |
| Date: | November 2011 |
| Status: | Published |
| URI: | http://eprints.soton.ac.uk/id/eprint/339787 |
Actions (login required)
 |
View Item |
